CML is a myeloproliferative neoplasm characterized by the chromosomal translocation t(9;22)(q34.1;q11.2), which results in the formation of the BCR-ABL1 fusion gene, encoding the BCR-ABL1 kinase [61]. The gene discussed is BCR; the disease is myeloproliferative disorder.